All Stories

  1. Vaccine-preventable HPV burden and cervical abnormalities in women during 2022–2024 Octobre Rose campaigns in Libreville
  2. Congenital measles: a case highlighting challenges in clinical interventions in a developing country
  3. Measles trend in Gabon: Insight from 18 years of surveillance data
  4. Clinical diagnostic accuracy of the HIV rapid test ACCU-TELL anti-HIV 1 + 2 in sub-Saharan African region
  5. Publisher Correction: Survey of the risk behaviors and mental health of adolescents in Gabon
  6. Virological Remission in Two HIV‐Infected Children After Early cART in Libreville, Gabon
  7. Survey of the risk behaviors and mental health of adolescents in Gabon
  8. Pediatric tuberculosis in a high burden setting: Socio-spatial distribution, blood elements features, and outcomes
  9. HIV-exposed uninfected infants’ immune defects: From pathogen sensing, oxidative burst to antigens responses
  10. Corrigendum: Microbiology laboratories involved in disease and antimicrobial resistance surveillance: Strengths and challenges of the central African states
  11. Changes of C-reactive protein and Procalcitonin after four weeks of treatment in patients with pulmonary TB
  12. Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8+ T lymphocytes, NK‐cells, and high frequency of CD73+ stromal cells
  13. Allergen sensitization and polysensitization pattern of adults and children in an urban Sub-Saharan African setting (Libreville, Gabon)
  14. Vitamin D2 versus vitamin D3 as a risk factor in compromised bone health
  15. Outcomes of severe malaria and its clinical features in Gabonese children
  16. Malaria beyond its predominant endemic regions: Emerging threat or sporadic events?
  17. Microbiology laboratories involved in disease and antimicrobial resistance surveillance: Strengths and challenges of the central African states
  18. Mapping Allergic Diseases in Sub-Saharan Africa
  19. Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon
  20. Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon
  21. SARS-CoV-2 emerging variants in Africa: view from Gabon
  22. Unrecognized introduction of SARS‐CoV‐2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent
  23. Profiles of microorganisms isolated from neonates’ blood cultures, incubators, cradles, ventilators, washbasins, and health-workers of Libreville University Hospital Neonatal Service: focus on infection prevention and control measures
  24. Dynamic and features of SARS-CoV-2 infection in Gabon
  25. Mycobacterium tuberculosis-stimulated whole blood culture to detect host biosignatures for tuberculosis treatment response
  26. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
  27. Case series of SARS‐COV‐2 infection in pregnant African women: focus on biological features
  28. Higher IL-8 Response to <i>Mycobacterium tuberculosis</i> Antigens in Women above 40 Years
  29. Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
  30. Escalating and sustained immunovirological dissociation among antiretroviral drug-experienced perinatally human immunodeficiency virus-1-infected children and adolescents living in the Central African Republic
  31. Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
  32. Increased platelets count in HIV-1 uninfected infants born from HIV-1 infected mothers
  33. M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis
  34. HIV-exposed uninfected compared with unexposed infants show the presence of leucocytes, lower lactoferrin levels and antimicrobial-resistant micro-organisms in the stool
  35. Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis
  36. Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy
  37. Mother-to-child HIV-transmission prevention programs in a sub-Saharan African setting: The Gabonese experience
  38. Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon
  39. Cases of Impaired Oxidative Burst in HIV-Exposed Uninfected Infants’ Neutrophils—A Pilot Study
  40. Metabolic Deregulation Associated with Glycemic Imbalance In Gabonese Diabetics
  41. Phytochemical screening, antioxidant and antimicrobial potential of stem barks of Coula edulis Baill. Pseudospondias longifolia Engl. and Carapa klaineana Pierre. from Gabon
  42. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis
  43. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance
  44. HIV, HBS, HCV, HTLV and syphilis prevalence among high school learners and university student in Libreville, Gabon
  45. Genital Mycoplasma infections and their resistance phenotypes in an African setting
  46. Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Africa
  47. Prevalence and Relationship between Hyperglycemia Hypertension and Obesity in Libreville-Gabon: A Pilot Study
  48. Correction: Chlamydia trachomatis, Human Immunodeficiency Virus (HIV) Distribution and Sexual Behaviors across Gender and Age Group in an African Setting
  49. Antimicrobial profiles of bacterial clinical isolates from the Gabonese National Laboratory of Public Health: data from routine activity
  50. Evaluation of blood donors questionnaire in a developing country: The case of Gabon
  51. Chlamydia trachomatis, Human Immunodeficiency Virus (HIV) Distribution and Sexual Behaviors across Gender and Age Group in an African Setting
  52. Oncomodulin and macrophages derived factors in pancreas injury and development paradigms
  53. Phytochemical screening and cytotoxicity studies of Chrysophyllum pruniforme Pierre ex Engl. barks
  54. Cytokines in Pulmonary Tuberculosis
  55. Biological and Toxicological Effects of Aqueous Acetone Extract of Cienfuegosia digitata Cav. (Malvaceae) in Mice and Rats
  56. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression
  57. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis
  58. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis
  59. Molecular Markers of Infectious Diseases
  60. Differential Cytokine Secretion and Early Treatment Response in Patients with Pulmonary Tuberculosis
  61. Biomarkers for TB treatment response: Challenges and future strategies
  62. An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays
  63. Differential Expression of Interleukin-4 (IL-4) and IL-4 2 mRNA, but Not Transforming Growth Factor Beta (TGF- ), TGF- RII, Foxp3, Gamma Interferon, T-bet, or GATA-3 mRNA, in Patients with Fast and Slow Responses to Antituberculosis Treatment
  64. Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response
  65. Correlates for disease progression and prognosis during concurrent HIV/TB infection